EDIT Archives » The Arora Report Stock Market News

WEEKLY STOCK MARKET DIGEST: STOCK MARKET REACHES TACTICAL PROFIT TAKING ZONE, POWELL’S FAVORITE INDICATOR PROVIDES NO RELIEF

By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules

July 30, 2022

STOCK BUYING ON HOPE STRATEGY AHEAD OF KEY EARNINGS, THE FED AND GDP

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Pivotal Week Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart compares S&P 500 ETF SPY with Nasdaq

July 25, 2022

VERY NICE GAINS ON GENE EDITING COMPANY EDITAS MEDICINE — TAKE PARTIAL PROFITS

This is the golden age of gene editing. Our view of gene editing company Editas Medicine (EDIT) is positive but a stock and a company are two different things. This stock has been highly pumped recently. This provided a trading opportunity from the short side. The stock was sold short

January 3, 2021